Varian Medical Systems, Inc. (NYSE:VAR) Position Held by Washington Capital Management Inc.

Washington Capital Management Inc. continued to hold its position in shares of Varian Medical Systems, Inc. (NYSE:VAR) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,600 shares of the medical equipment provider’s stock at the end of the second quarter. Washington Capital Management Inc.’s holdings in Varian Medical Systems were worth $475,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in VAR. DnB Asset Management AS raised its position in shares of Varian Medical Systems by 16.2% in the first quarter. DnB Asset Management AS now owns 200,533 shares of the medical equipment provider’s stock worth $18,275,000 after buying an additional 28,000 shares during the period. SFE Investment Counsel raised its position in shares of Varian Medical Systems by 17.7% in the first quarter. SFE Investment Counsel now owns 45,447 shares of the medical equipment provider’s stock worth $4,142,000 after buying an additional 6,829 shares during the period. TNB Financial acquired a new position in shares of Varian Medical Systems during the first quarter worth about $7,542,000. CrestPoint Capital Management LLC acquired a new position in shares of Varian Medical Systems during the first quarter worth about $419,000. Finally, Gulf International Bank UK Ltd raised its position in shares of Varian Medical Systems by 1.4% in the first quarter. Gulf International Bank UK Ltd now owns 31,725 shares of the medical equipment provider’s stock worth $2,891,000 after buying an additional 450 shares during the period. Institutional investors and hedge funds own 98.95% of the company’s stock.

Varian Medical Systems, Inc. (VAR) opened at 100.50 on Friday. The stock’s 50 day moving average price is $101.14 and its 200 day moving average price is $94.15. Varian Medical Systems, Inc. has a 1-year low of $75.20 and a 1-year high of $107.08. The firm has a market cap of $9.23 billion, a P/E ratio of 33.08 and a beta of 0.61.

Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, July 26th. The medical equipment provider reported $1.04 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.09. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The business had revenue of $662.40 million during the quarter, compared to analysts’ expectations of $663.86 million. During the same quarter last year, the business posted $1.00 earnings per share. The company’s quarterly revenue was up 3.0% on a year-over-year basis. Equities research analysts predict that Varian Medical Systems, Inc. will post $3.93 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Varian Medical Systems, Inc. (NYSE:VAR) Position Held by Washington Capital Management Inc.” was originally published by BNB Daily and is owned by of BNB Daily. If you are viewing this story on another site, it was stolen and reposted in violation of US and international copyright & trademark law. The legal version of this story can be accessed at https://www.baseball-news-blog.com/2017/08/19/washington-capital-management-inc-holds-stake-in-varian-medical-systems-inc-nysevar-updated-updated.html.

A number of equities analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of Varian Medical Systems from a “buy” rating to a “hold” rating in a research report on Thursday, July 13th. BidaskClub upgraded shares of Varian Medical Systems from a “buy” rating to a “strong-buy” rating in a research report on Thursday, July 13th. Robert W. Baird reiterated a “neutral” rating and issued a $99.00 price objective (up from $89.00) on shares of Varian Medical Systems in a research report on Friday, July 14th. Goldman Sachs Group, Inc. (The) began coverage on shares of Varian Medical Systems in a research report on Tuesday, May 16th. They issued a “neutral” rating and a $92.00 price objective on the stock. Finally, Jefferies Group LLC reiterated a “buy” rating on shares of Varian Medical Systems in a research report on Thursday, May 11th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $96.28.

In related news, insider Dow R. Wilson sold 15,059 shares of the firm’s stock in a transaction dated Monday, August 7th. The stock was sold at an average price of $96.48, for a total transaction of $1,452,892.32. Following the completion of the transaction, the insider now owns 81,835 shares of the company’s stock, valued at $7,895,440.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Mark R. Laret sold 1,428 shares of the firm’s stock in a transaction dated Thursday, June 8th. The shares were sold at an average price of $103.47, for a total value of $147,755.16. Following the transaction, the director now directly owns 3,289 shares of the company’s stock, valued at approximately $340,312.83. The disclosure for this sale can be found here. Insiders have sold 159,372 shares of company stock valued at $16,128,658 in the last ninety days. Company insiders own 0.91% of the company’s stock.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply